This metabolite provides a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 about fifty% of the mother or father drug. Plasma concentrations of the metabolite are approximately 40% of These seen for sildenafil, so that the metabolite accounts for around 20% of sildenafil’s pharmacologic consequences.Viagra is also